There's a high level of competitiveness in certain disease categories. Non small cell lung cancer is one of the most highly researched conditions for clinical trials. Unfortunately, due to HIPAA, you can't analyze somebody's medical records and then send them an email on the basis of that. So those like micro instances of supply demand imbalance also probably create like create environments where it's harder to recruit.
This week, we’re super excited to have Brandon Li, co-CEO and co-founder of Power, a platform to find promising new treatments through clinical trials. Power’s platform allows patients and providers to search every trial currently available in the U.S. It includes over 30,000 clinical trials and 100,000 researchers spanning 10,000 medical conditions.
In Aug 2022, Power announced a $7M seed round led by Footwork and CRV.
Brandon has spent a long time building and scaling consumer marketplace platforms to help people navigate traditionally opaque industries. Prior to founding Power, Brandon was the Head of Bizops at Thumbtack where he led growth strategy for the Home improvement marketplace. He landed at Thumbtack after Setter was acquired, where he was the GM of California. Before Setter, he spent time at McKinsey as an Engagement Manager focused on fast growth marketplace clients.
Brandon has a background in high growth companies—Brandon is a serial entrepreneur, starting multiple companies across logistics, hometech and even suits! Another native guest from Canada, Brandon graduated from University of Toronto in Industrial Engineering.
In this episode, we discuss how to navigate the idea maze, building from patient perspectives, and the emerging field of new pharma tech companies.